Oxford Covid-19 vaccine stimulates broad antibody and T cell functions – study

Vials of the Oxford coronavirus vaccine (Sean Elias/University of Oxford)

The University of Oxford’s coronavirus vaccine stimulates broad antibody and T cell responses, published trial results show.

Researchers published further data from phase one/two clinical trials of the ChAdOx1 nCoV-19 Covid-19 vaccine, showing the evidence for the decision to move to a two-dose regimen in ongoing phase three trials.